HighTower Advisors
RMD icon

HighTower Advisors’s ResMed RMD Stock Holding History

HighTower Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$585 – 4002
2024
Q4 		$585 Hold
100
– – ﹤0.01% 3727
2024
Q3 		$2.95K Buy
+100
New +$22.3K ﹤0.01% 3618
2020
Q2 		– Sell
-100
Closed -$2K – 2521
2020
Q1 		$2K Buy
+100
New +$15.9K ﹤0.01% 2182

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HighTower Advisors's RMD Position: Q1 2026 in Review

HighTower Advisors reduced its ResMed (RMD) stake by 39% in Q1 2026, selling an estimated $3.42M and leaving 21,025 shares worth $4.72M. The position accounts for 0.01% of the portfolio, ranked #1225.

HighTower Advisors first reported a position in RMD in Q1 2014 and has held it in 47 quarters since. The position peaked at $19.9M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • HighTower Advisors held 21,025 shares of ResMed worth $4.72M as of Q1 2026.
  • HighTower Advisors sold 13,719 ResMed shares in Q1 2026, an estimated $3.42M.
  • ResMed made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #1225 holding.
  • HighTower Advisors first reported a position in ResMed in Q1 2014 and has held it in 47 quarters since.
  • HighTower Advisors's ResMed position peaked at $19.9M in Q4 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.